Alzheimer's Disease Trial, Recruiting NCT07361887 Sponsor: University of Seville Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07361887
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who are generally healthy, between 35 and 65 years old, both men and women
  • People with a Body Mass Index (BMI) between 18.5 and 29.9 (a measure of body weight relative to height that falls within the "normal" to "overweight" range)
  • People who do not smoke, or who stopped smoking at least 12 months ago
  • People who drink alcohol only in moderate amounts — no more than 2 standard drinks per day for men, and no more than 1 standard drink per day for women
  • People whose blood sugar and cholesterol levels are normal at the initial screening check
  • People who are willing and able to avoid alcohol, certain foods high in plant compounds (such as berries, tea, and red wine), and intense physical activity for 48 hours before each study visit
  • People who can understand what the study involves and who agree to take part by signing a consent form

Who may not be able to join:

  • People who have a history of, or signs of, heart, liver, kidney, thyroid, digestive, or metabolic conditions — including diabetes, abnormal cholesterol levels, or high blood pressure
  • People who are currently taking medications or supplements that are known to affect blood sugar, cholesterol, or inflammation — for example, statins, steroids, or anti-inflammatory medicines
  • People who are pregnant or breastfeeding
  • People who have donated blood in the past 3 months, or who plan to donate blood during the study period
  • People whose body weight has changed by more than 5% in the last 3 months
  • People who have taken part in another clinical or medical research study in the past 3 months
  • People who have a known allergy or intolerance to wine, alcohol, or related ingredients such as sulfites
  • People who have a history of alcohol misuse, or who would be unable to avoid drinking alcohol outside of what the study allows
  • People who would not want to be told about any unexpected health findings that may come up during the study
  • People with any condition — such as certain mental health conditions or difficulty following fasting instructions — that the study investigators consider may affect safe or full participation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34 605383541

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Seville
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
1 December 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Concentration of circulating extracellular vesicles; Mean size of circulating extracellular vesicles

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov